Views & Analysis

Views & Analysis
Crowd of people gathering at center, men and women, different ethnic groups and clothing

Accelerating access for rare disease patients – the need to ...

Santhera is putting patient needs at the heart of its rare disease speciality business. Chief Executive Officer Thomas Meier, PhD, talks about the company’s mission – and how rationalising Europe’s drug review systems could help patients.

Debates & Insight
Paid medicine. Cost of treatment. Isolated 3D image
Sponsored

Pricing and Market Access Outlook 2018

This year’s edition of Pricing and Market Access Outlook, our first as IQVIA, identifies a trend towards models that reward value and outcomes.